Multidrug Resistance and Cancer Stem Cells in Neuroblastoma and Hepatoblastoma
Chemotherapy is one of the major modalities in treating cancers. However, its effectiveness is limited by the acquisition of multidrug resistance (MDR). Several mechanisms could explain the up-regulation of MDR genes/proteins in cancer after chemotherapy. It is known that cancer stem cells (CSCs) pl...
Main Authors: | Anna Alisi, William C. Cho, Franco Locatelli, Doriana Fruci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/12/24706 |
Similar Items
-
Genetic Profile and Clinical Implications of Hepatoblastoma and Neuroblastoma Coexistence in a Child
by: Szymon Skoczen, et al.
Published: (2019-04-01) -
Extrahepatic hepatoblastoma- an extremely rare occurrence
by: Y.K. Sarin, et al.
Published: (2021-04-01) -
Hepatoblastoma survival and the prognostic role of cancer stem cell markers
by: Mohamed Fawzy, et al.
Published: (2014-02-01) -
Hepatomegaly as the first symptom of malignant solid tumors in children
by: Karolina Widłak, et al.
Published: (2018-05-01) -
Unresectable hepatoblastoma: current perspectives
by: Trobaugh-Lotrario AD, et al.
Published: (2017-02-01)